References to "the Company," "our," "us" or "we" refer to Oxbridge Acquisition
Corp. The following discussion and analysis of our financial condition and
results of operations should be read in conjunction with our audited financial
statements and the notes related thereto which are included in "Item 8.
Financial Statements and Supplementary Data" of this Annual Report on Form 10-K.
Certain information contained in the discussion and analysis set forth below
includes forward-looking statements. Our actual results may differ materially
from those anticipated in these forward-looking statements as a result of many
factors, including those set forth under "Special Note Regarding Forward-Looking
Statements," "Item 1A. Risk Factors" and elsewhere in this Annual Report on Form
10-K.
In this Amendment No. 1, we are restating (i) the Post IPO Balance Sheet, as
previously revised in the First Amended Filing, and (ii) the audited financial
statements for the period from April 12, 2021 (inception) to December 31, 2021
as previously filed in the Original Filing.
We have re-evaluated our application of ASC 480-10-S99-3A to our accounting and
classification of the Public Shares, issued as part of the units sold in the
initial public offering on August 16, 2021. Historically, a portion of the
Public Shares was classified as permanent equity to maintain shareholders'
equity greater than $5 million on the basis that we will not redeem our Public
Shares in an amount that would cause our net tangible assets to be less than
$5,000,001, as described in the amended and restated memorandum and articles of
association. Pursuant to such re-evaluation, our management has determined that
the Public Shares include certain provisions that require classification of all
of the Public Shares as temporary equity regardless of the net tangible assets
redemption limitation contained in the amended and restated memorandum and
articles of association.
On February 15, 2023, the Audit Committee concluded, after discussion with the
Company's management and consultation with Hacker Johnson Smith P.A., that our
previously issued i) audited balance sheet as of August 16, 2021 (the "Post IPO
Balance sheet"), (ii) unaudited financial statements included in our Quarterly
Report on Form 10-Q for the quarterly period ended September 30, 2021, filed
with the SEC on November 15, 2021 (iii) audited financial statements included in
the Annual Report on Form 10-K for the period from April 12, 2021 (inception) to
December 31, 2021, filed with the SEC on March 30, 2022, (iv) unaudited
financial statements included in our Quarterly Report on Form 10-Q for the
quarterly period ended March 31, 2022, filed with the SEC on May 12, 2022, (v)
unaudited financial statements included in our Quarterly Report on Form 10-Q for
the quarterly period ended June 30, 2022, filed with the SEC on August 15, 2022,
and (vi) unaudited financial statements included in our Quarterly Report on Form
10-Q for the quarterly period ended September 30, 2022, filed with the SEC on
November 14, 2022 should be restated to report all Public Shares as temporary
equity and should no longer be relied upon.
The restatement does not have an impact on our total assets or total
liabilities, net income (loss), cash flows or cash position.
Our management has concluded that in light of the classification error described
above, a material weakness exists in our internal control over financial
reporting and that our disclosure controls and procedures were not effective as
of December 31, 2021. In connection with the restatement, our management
reassessed the effectiveness of our disclosure controls and procedures for the
periods affected by the restatement. As a result of that reassessment, we
determined that our disclosure controls and procedures for such periods were not
effective with respect to our internal controls around the proper accounting and
classification of complex financial instruments. For more information, see Item
9A included in this Amendment No. 1. The restatement is more fully described in
Note 2 of the notes to the financial statements included herein.
Forward Looking Statements
All statements other than statements of historical fact included in this Form
10-K including, without limitation, statements under "Management's Discussion
and Analysis of Financial Condition and Results of Operations" regarding our
financial position, business strategy and the plans and objectives of management
for future operations, are forward-looking statements. When used in this Form
10-K, words such as "anticipate," "believe," "estimate," "expect," "intend" and
similar expressions, as they relate to us or our management, identify
forward-looking statements. Such forward-looking statements are based on the
beliefs of management, as well as assumptions made by, and information currently
available to, our management. Actual results could differ materially from those
contemplated by the forward-looking statements as a result of certain factors
detailed in our filings with the SEC.
The following discussion and analysis of our financial condition and results of
operations should be read in conjunction with the financial statements and the
notes thereto contained elsewhere in this Form 10-K. Certain information
contained in the discussion and analysis set forth below includes
forward-looking statements that involve risks and uncertainties.
40
Overview
We are a Cayman Islands exempted company incorporated on April 12, 2021, for the
purpose of entering into a merger, share exchange, asset acquisition, share
purchase, recapitalization, reorganization or other similar business combination
with one or more target businesses (the "Business Combination").
Our sponsor is OAC Sponsor Ltd., a Cayman Islands exempted company (the
"Sponsor"). The registration statement for our initial public offering ("IPO")
was declared effective on August 11, 2021. On August 16, 2021, we consummated
our IPO of 10,000,000 units (each, a "Unit" and collectively, the "Units" and,
with respect to the Class A ordinary shares included in the Units, the "Public
Shares"), at $10.00 per Unit, generating gross proceeds of $100,000,000 and
incurring offering costs of approximately $6,624,000, inclusive of $3,500,000 in
deferred underwriting commissions. The underwriters exercised the over-allotment
option in full and on August 16, 2021, purchased an additional 1,500,000 units
(the "Over-Allotment Units"), generating additional gross proceeds of
$15,000,000 (the "Over-Allotment"), and incurring additional offering costs of
$825,000, inclusive of $525,000 of deferred underwriting commissions.
Substantially concurrently with the closing of our IPO, we completed the private
sale (the "private placement") of 5,760,000 warrants to the Sponsor and Maxim
Group LLC ("Maxim"), the underwriter in our IPO, at a price of $1.00 per private
placement warrant, generating gross proceeds of $5,760,000.
Upon the closing of our IPO and the private placement, $116,725,000
(approximately $10.15 per Unit) from the net proceeds of the sale of the Units
in the IPO, including a portion of the proceeds from the private placement, was
deposited in a trust account, located in the United States with Continental
Stock Transfer & Trust Company acting as trustee, which may only be invested in
permitted United States "government securities" within the meaning of Section
2(a)(16) of the Investment Company Act of 1940, as amended, having a maturity of
185 days or less or in money market funds meeting certain conditions under Rule
2a-7 promulgated under the Investment Company Act that invest only in direct
U.S. government treasury obligations.
Our management has broad discretion with respect to the specific application of
the net proceeds of the IPO and the sale of the private placement warrants,
although substantially all of the net proceeds are intended to be applied
generally toward consummating a Business Combination.
We will have 15 months through to November 16, 2022 (or up to 21 months through
to May 16, 2023 if we extend the period of time to consummate a business
combination by the full amount of time), to complete the initial Business
Combination (the "Combination Period"). However, if we are unable to complete
the initial Business Combination within the Combination Period, we will (i)
cease all operations except for the purpose of winding up, (ii) as promptly as
reasonably possible but not more than ten business days thereafter, redeem the
public shares, at a per-share price, payable in cash, equal to the aggregate
amount then on deposit in the trust account including interest earned on the
funds held in the trust account and not previously released to us to pay the our
taxes (less up to $100,000 of interest to pay dissolution expenses), divided by
the number of then outstanding public shares, which redemption will completely
extinguish public shareholders' rights as shareholders (including the right to
receive further liquidating distributions, if any), subject to applicable law,
and (iii) as promptly as reasonably possible following such redemption, subject
to the approval of our remaining shareholders and board of directors, liquidate
and dissolve, subject in each case to our obligations under Cayman Islands law
to provide for claims of creditors and the requirements of other applicable law.
41
Liquidity and Capital Resources
As of December 31, 2021 we had cash of approximately $614,000 and a working
capital of approximately $596,000 to satisfy our liquidity needs. Prior to the
completion of our IPO, our liquidity needs had been satisfied through a capital
contribution from the Sponsor of $25,000 for the founder shares, the loan under
an unsecured promissory note from the Sponsor of up to $300,000, of which
approximately $195,000 was drawn upon and subsequently repaid after the IPO.
In order to fund working capital deficiencies or finance transaction costs in
connection with an intended initial business combination, our sponsor or an
affiliate of our sponsor or certain of our officers and directors may, but are
not obligated to, loan us funds as may be required. If we complete our initial
business combination, we would repay such loaned amounts. In the event that our
initial business combination does not close, we may use a portion of the working
capital held outside the trust account to repay such loaned amounts but no
proceeds from our trust account would be used for such repayment. Up to
$1,500,000 of such working capital loans may be convertible into private
placement-equivalent warrants at a price of $1.00 per warrant (which, for
example, would result in the holders being issued 1,500,000 warrants if
$1,500,000 of notes were so converted), at the option of the lender. Such
warrants would be identical to the private placement warrants, including as to
exercise price, exercisability and exercise period. The terms of such working
capital loans by our sponsor or its affiliates, or our officers and directors,
if any, have not been determined and no written agreements exist with respect to
such loans. Prior to the completion of our initial business combination, we do
not expect to seek loans from parties other than our sponsor or an affiliate of
our sponsor as we do not believe third parties will be willing to loan such
funds and provide a waiver against any and all rights to seek access to funds in
our trust account. As of December 31, 2021, there were no amounts outstanding
under any working capital loans.
Based on the foregoing, management believes that we may have sufficient working
capital and borrowing capacity to meet its needs through the earlier of the
consummation of a Business Combination or one year from this filing. Over this
time period, we will be using these funds to pay existing accounts payable,
identifying and evaluating prospective initial Business Combination candidates,
performing due diligence on prospective target businesses, paying for travel
expenditures, selecting the target business to merge with or acquire, and
structuring, negotiating and consummating the Business Combination.
Risks and Uncertainties
Management continues to evaluate the impact of the COVID-19 pandemic and has
concluded that while it is reasonably possible that the virus could have a
negative effect on our financial position, results of its operations, and/or
search for a target company, the specific impact is not readily determinable as
of the date of these audited financial statements. The audited financial
statements do not include any adjustments that might result from the outcome of
this uncertainty.
Results of Operations
As of December 31, 2021, we had not commenced any operations. All activity for
the period from April 12, 2021 (inception) through December 31, 2021 relates to
our formation and the IPO. We have neither engaged in any operations nor
generated any revenues to date. We will not generate any operating revenues
until after the completion of our initial Business Combination, at the earliest.
We may generate non-operating income in the form of interest income and
unrealized gains from the proceeds derived from the IPO. We expect to incur
increased expenses as a result of being a public company (for legal, financial
reporting, accounting and auditing compliance), as well as for due diligence
expenses.
For the period from April 12, 2021 (inception) through to December 31, 2021, we
had a net loss of approximately $3.54 million, which consisted of an
approximately $85,000 in general and administrative expenses and approximately
$3.46 million loss on warrant liability revaluation.
42
Contractual Obligations
Other than the below, we do not have any long-term debt obligations, capital
lease obligations, operating lease obligations, purchase obligations or
long-term liabilities.
Administrative Services Agreement
Commencing on the date that our securities are first listed, we agreed to pay
the Sponsor $10,000 per month for office space, secretarial and administrative
services provided to members of our founding team. Upon completion of the
initial Business Combination or our liquidation, we will cease paying such
monthly fees. As of December 31, 2021, we have recognized and paid $50,000 under
the Administrative Services Agreement, which is included within Formation and
Administrative Expenses on the Statement of Operations.
Registration Rights
The holders of the founder shares, private placement warrants, Class A ordinary
shares underlying the private placement warrants and warrants that may be issued
upon conversion of Working Capital Loans (and any Class A ordinary shares
issuable upon the exercise of the private placement warrants and warrants that
may be issued upon conversion of working capital loans) will be entitled to
registration rights pursuant to a registration and shareholder rights agreement.
The holders of these securities are entitled to make up to three demands,
excluding short form demands, that we register such securities. In addition, the
holders have certain "piggy-back" registration rights with respect to
registration statements filed subsequent to our completion of the initial
Business Combination. We will bear the expenses incurred in connection with the
filing of any such registration statements.
Underwriting Agreement
On August 16, 2021, we paid an underwriting discount of 2% of the per Unit
offering price, or approximately $2,300,000 million in the aggregate at the
closing of the IPO, and the underwriters are entitled to a deferred underwriting
discount of 3.5% of the gross proceeds of the IPO, or $4,025,000 in the
aggregate. The deferred fee will be payable to the underwriters from the amounts
held in the trust account solely in the event that we complete an initial
Business Combination, subject to the terms of the underwriting agreement.
Critical Accounting Policies
Derivative financial instruments
We do not use derivative instruments to hedge exposures to cash flow, market, or
foreign currency risks. We evaluate all of our financial instruments, including
issued stock purchase warrants, to determine if such instruments are derivatives
or contain features that qualify as embedded derivatives, pursuant to ASC 480
and ASC 815, "Derivatives and Hedging" ("ASC 815"). The classification of
derivative instruments, including whether such instruments should be recorded as
liabilities or as equity, will be re-assessed at the end of each reporting
period. Derivative warrant liabilities will be classified as non-current
liabilities as their liquidation is not reasonably expected to require the use
of current assets or require the creation of current liabilities.
The 17,260,000 warrants issued on August 16, 2021 in connection with the IPO and
the private placement (including the 11,500,000 warrants included in the Units
and the 5,760,000 private placement warrants) are recognized as derivative
liabilities in accordance with ASC 815. The liabilities are subject to
re-measurement at each balance sheet date until exercised, and any change in
fair value is recognized in our statement of operations. The fair value of the
Public Warrants issued in connection with the Public Offering were initially
measured at fair value using a Black-Scholes option pricing model simulation
model and subsequently, the fair value of Public Warrants issued in connection
with the IPO have been measured based on the listed market price of such
warrants as of December 31, 2021. The fair value of the Private Warrants has
been estimated initially and subsequently, as of December 31, 2021, using a
modified version of the Black-Scholes option pricing model. The determination of
the fair value of the warrant liabilities may be subject to change as more
current information becomes available and accordingly the actual results could
differ significantly. Derivative warrant liabilities are classified as
non-current liabilities as their liquidation is not reasonably expected to
require the use of current assets or require the creation of current
liabilities.
43
Class A Ordinary Shares Subject to Possible Redemption
As of December 31, 2021, there were 11,615,000 Class A ordinary shares issued or
outstanding. We accounts for our Class A ordinary shares subject to possible
redemption in accordance with the guidance in Accounting Standards Codification
("ASC") Topic 480 "Distinguishing Liabilities from Equity." Ordinary shares
subject to mandatory redemption are classified as a liability instrument and is
measured at fair value. Conditionally redeemable ordinary shares (including
ordinary shares that features redemption rights that is either within the
control of the holder or subject to redemption upon the occurrence of uncertain
events not solely within our control) are classified as temporary equity. At all
other times, ordinary shares are classified as shareholders' equity. Our
ordinary shares features certain redemption rights that are considered to be
outside of our control and be subject to occurrence of uncertain future events.
Accordingly, at December 31, 2021, 11,500,000 Class A ordinary shares subject to
possible redemption are presented at redemption value as temporary equity,
outside of the shareholders' equity section of our balance sheets.
Loss Per Ordinary Share
Loss per share is computed by dividing (loss) earnings by the weighted average
number of ordinary shares outstanding during the period. At December 31, 2021,
we did not have any dilutive securities and other contracts that could,
potentially, be exercised or converted into ordinary shares and then share in
our (loss) earnings. As a result, diluted loss per share is the same as basic
loss per share for the period presented.
Balance Sheet Arrangements
As of December 31, 2021, we did not have any off-balance sheet arrangements as
defined in Item 303(a)(4)(ii) of Regulation S-K.
Inflation
We do not believe that inflation had a material impact on our business, revenues
or operating results during the period presented.
Emerging Growth Company Status
We are an "emerging growth company," as defined in Section 2(a) of the
Securities Act, as modified by the Jumpstart our Business Startups Act of 2012,
(the "JOBS Act"), and may take advantage of certain exemptions from various
reporting requirements that are applicable to other public companies that are
not emerging growth companies including, but not limited to, not being required
to comply with the auditor attestation requirements of Section 404 of the
Sarbanes-Oxley Act, reduced disclosure obligations regarding executive
compensation in its periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote on executive compensation
and stockholder approval of any golden parachute payments not previously
approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies
from being required to comply with new or revised financial accounting standards
until private companies (that is, those that have not had a Securities Act
registration statement declared effective or do not have a class of securities
registered under the Exchange Act) are required to comply with the new or
revised financial accounting standards. The JOBS Act provides that a company can
elect to opt out of the extended transition period and comply with the
requirements that apply to non-emerging growth companies but any such election
to opt out is irrevocable. We have elected not to opt out of such extended
transition period which means that when a standard is issued or revised and it
has different application dates for public or private companies, we, as an
emerging growth company, can adopt the new or revised standard at the time
private companies adopt the new or revised standard. This may make comparison of
our financial statements with another public company which is neither an
emerging growth company nor an emerging growth company which has opted out of
using the extended transition period difficult or impossible because of the
potential differences in accounting standards used.
44
© Edgar Online, source Glimpses